Christopher Davis’s Medtronic MDT Stock Holding History

Christopher Davis’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-352,932	Closed	-$18.2M	–	203
2013 Q2	$18.2M	Buy	+352,932	New	+$17.4M	0.05%	95

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Christopher Davis's MDT Position: Q3 2013 in Review

Christopher Davis sold out of Medtronic (MDT) in Q3 2013, closing a stake of 352,932 shares — an estimated $18.2M sold.

Christopher Davis first reported a position in MDT in Q2 2013 and held it in 1 quarter. The position peaked at $18.2M in Q2 2013. 994 funds tracked by Wall St. Rank hold MDT as of Q3 2013.

Christopher Davis reported no remaining Medtronic position as of Q3 2013 after selling out during the quarter.
Christopher Davis sold 352,932 Medtronic shares in Q3 2013, an estimated $18.2M.
Christopher Davis first reported a position in Medtronic in Q2 2013 and held it in 1 quarter.
Christopher Davis's Medtronic position peaked at $18.2M in Q2 2013.
994 funds tracked by Wall St. Rank held Medtronic as of Q3 2013.

Based on Davis Selected Advisers's 13F filing for Q3 2013, filed 12 Nov 2013.